🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PET scanning (positron emission tomography) is a well-established technique...
Status
Completed
Location
Queen's Medical Research Institute
Start Date
2018-05-01
Trial ID
NCT03626571
Treatments Being Tested
PET imaging of activated microglia offers a tool of investigation of a rang...
Status
Unknown
Location
Service de Médecine Nucléaire et Ultrasons - Hôpital Bretonneau
Start Date
2007-01
Trial ID
NCT00563537
Treatments Being Tested
It is not known whether radiological assessments during follow up after sur...
Status
Recruiting
Location
Södra Älvsborgs sjukhus
Start Date
2017-06-08
Trial ID
NCT03116412
Treatments Being Tested
The early detection of a preclinical AD or early stage of AD with amyloid i...
Status
Terminated
Location
University Hospital Case Medical Center
Start Date
2013-10
Trial ID
NCT02343757
Treatments Being Tested
The purpose of this study is to assess the safety, biodistribution, dosimet...
Status
Unknown
Location
Xijing Hospital Nuclear Medicine Department
Start Date
2014-06
Trial ID
NCT02327442
Treatments Being Tested
This phase I trial studies the safety and side effects of a new positron em...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-09-14
Trial ID
NCT07619599
This study will use Prostate Specific Membrane Antigen (PSMA) and (18)F-Flu...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2025-04-03
Trial ID
NCT06335914
Treatments Being Tested
The current understanding of acute myeloid leukemia (AML) is that one site ...
Status
Unknown
Location
Juravinski Hospital and Cancer Center
Start Date
2016-04
Trial ID
NCT02682732
Treatments Being Tested
This phase 0 trial studies whole body fluorine F 18 sodium fluoride positro...
Status
Completed
Location
Massachusetts General Hospital Cancer Center
Start Date
2010-03
Trial ID
NCT00956163
This study evaluated the safety, efficacy and toxicity of carboplatin area ...
Status
Completed
Location
Barts Health NHS Trust
Start Date
2012-02-13
Trial ID
NCT02272816
Treatments Being Tested